Maravai Lifesciences Holdings, Inc. announced that Brian Neel, Chief Operating Officer, Nucleic Acid Production notified the Company of his decision to resign to pursue other interests effective March 31, 2023. Andrew Burch, previously an executive at Thermo Fisher Scientific, has joined the Company and will assume the role of Executive Vice President and General Manager of the Company's Nucleic Acid Products Operating Division following Mr. Neel's departure on March 31st.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 USD | -0.57% | -19.29% | +32.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.82% | 1.16B | |
+3.25% | 3.43B | |
-0.37% | 2.27B | |
-19.19% | 2.03B | |
-22.57% | 1.63B | |
+14.12% | 714M | |
-8.30% | 703M | |
-31.22% | 500M | |
-4.97% | 279M | |
-16.50% | 161M |
- Stock Market
- Equities
- MRVI Stock
- News Maravai LifeSciences Holdings, Inc.
- Maravai Lifesciences Holdings, Inc. Announces Executive Changes